Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Walker, Alan W
Westendorf, Astrid M
Macpherson, Andrew J
von Mering, Christian
MetadataShow full item record
AbstractMost mucosal surfaces of the mammalian body are colonized by microbial communities ("microbiota"). A high density of commensal microbiota inhabits the intestine and shields from infection ("colonization resistance"). The virulence strategies allowing enteropathogenic bacteria to successfully compete with the microbiota and overcome colonization resistance are poorly understood. Here, we investigated manipulation of the intestinal microbiota by the enteropathogenic bacterium Salmonella enterica subspecies 1 serovar Typhimurium (S. Tm) in a mouse colitis model: we found that inflammatory host responses induced by S. Tm changed microbiota composition and suppressed its growth. In contrast to wild-type S. Tm, an avirulent invGsseD mutant failing to trigger colitis was outcompeted by the microbiota. This competitive defect was reverted if inflammation was provided concomitantly by mixed infection with wild-type S. Tm or in mice (IL10(-/-), VILLIN-HA(CL4-CD8)) with inflammatory bowel disease. Thus, inflammation is necessary and sufficient for overcoming colonization resistance. This reveals a new concept in infectious disease: in contrast to current thinking, inflammation is not always detrimental for the pathogen. Triggering the host's immune defence can shift the balance between the protective microbiota and the pathogen in favour of the pathogen.
CitationSalmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. 2007, 5 (10):2177-89 PLoS Biol.
AffiliationInstitute of Microbiology, Swiss Institute of Technology Zurich, Zurich, Switzerland.
The following license files are associated with this item:
- The intestinal microbiota plays a role in Salmonella-induced colitis independent of pathogen colonization.
- Authors: Ferreira RB, Gill N, Willing BP, Antunes LC, Russell SL, Croxen MA, Finlay BB
- Issue date: 2011
- Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract.
- Authors: Barman M, Unold D, Shifley K, Amir E, Hung K, Bos N, Salzman N
- Issue date: 2008 Mar
- Flagella and chemotaxis are required for efficient induction of Salmonella enterica serovar Typhimurium colitis in streptomycin-pretreated mice.
- Authors: Stecher B, Hapfelmeier S, Müller C, Kremer M, Stallmach T, Hardt WD
- Issue date: 2004 Jul
- Persistent <i>Salmonella enterica</i> serovar Typhimurium Infection Increases the Susceptibility of Mice to Develop Intestinal Inflammation.
- Authors: Schultz BM, Salazar GA, Paduro CA, Pardo-Roa C, Pizarro DP, Salazar-Echegarai FJ, Torres J, Riedel CA, Kalergis AM, Álvarez-Lobos MM, Bueno SM
- Issue date: 2018
- An Oxidative Central Metabolism Enables Salmonella to Utilize Microbiota-Derived Succinate.
- Authors: Spiga L, Winter MG, Furtado de Carvalho T, Zhu W, Hughes ER, Gillis CC, Behrendt CL, Kim J, Chessa D, Andrews-Polymenis HL, Beiting DP, Santos RL, Hooper LV, Winter SE
- Issue date: 2017 Sep 13